Medical Cannabis Remediation and Testing Rulemaking Approval Resolution of 2025
DC approves medical cannabis testing and remediation rules to establish safety standards and quality controls for patient products through regulatory rulemaking.
DC approves medical cannabis testing and remediation rules to establish safety standards and quality controls for patient products through regulatory rulemaking.
This resolution authorizes the District of Columbia to approve and implement new regulatory rules governing the remediation and testing of medical cannabis products. The bill establishes standards and procedures for how cannabis products must be tested for potency, contaminants, and safety before reaching patients, and what remediation processes are acceptable if products fail initial testing.
Medical cannabis patients depend on reliable, safe products, and testing/remediation standards directly affect product quality and consumer safety. These rules create accountability in DC's medical cannabis supply chain and help prevent contaminated or mislabeled products from reaching vulnerable patient populations. Clear regulations also provide legal certainty for licensed cannabis businesses operating in the district.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.